AT-GC BioPharm was founded in 2004 with a vision that still drives us today: to transcend the limits of biopharmaceutical manufacturingsm. We believe that by applying the methods of leading technologies to the art of miniaturization, automation and control systems, we will develop breakthrough technology platform that will fundamentally change the way biopharmaceuticals are manufactured. We at AT-GC BioPharm are following the principle that the quality of the product can be assured only by focusing the attention on the product rather than documentary requirements. Only product focused quality approach, when used with the regulatory agency required documentary approach will meet the stringent safety requirements of educated society and consumers.
In its early years, AT-GC BioPharm focused on building top-notch science and business teams to help achieve this vision. Attracted by our scientific leadership, entrepreneurial spirit, and aggressive but judicious growth, AT-GC BioPharm quickly began to earn the attention and respect of many of the best scientists and business people from around the world.
Beginning in 20044, AT-GC BioPharm created strategic alliances with pharmaceutical and biotechnology companies. These alliances provided AT-GC BioPharm with leading edge technologies that we used to develop and enhance our intelligent manufacturing platform and related products. With an innovative, integrated science and technology platform, expertise in drug-target manufacturing, the company is geared for Quality Assured ManufacturingTM.
As AT-GC BioPharm is nearing its first anniversary, the company has revenue pipeline.
Today, AT-GC BioPharm has two leading products, proven commercial capabilities, and many product candidates in varying stages of development. We are continually evolving to ensure that our research and development efforts stay current with the demand for new biosensor and manufacturing related products that will make a genuine difference in the way biopharmaceuticals are manufactured.
